Status:
TERMINATED
A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension
Lead Sponsor:
Egalet Ltd
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the efficacy of the Egalet® controlled release formulation to an immediate release Carvedilol tablet.
Eligibility Criteria
Inclusion
- Have a diagnosis of mild or moderate primary hypertension
- Be able to tolerate a 2 week washout phase followed by a 2 week Placebo run- in phase
- Be minimum 18 years of age
Exclusion
- Be intolerant to alfa- or beta-blockers
- Have secondary causes of hypertension
- Be taking more than two antihypertensive medications
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00444834
Start Date
April 1 2007
End Date
May 1 2007
Last Update
August 29 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 02
Esbjerg, Denmark
2
Site 01
Frederiksberg, Denmark